IP Library Granted Patent US 9,028,857
Granted Patent B2
US 9,028,857 · App. 12/681,676 · Granted May 12, 2015

Method for preparing porous scaffold for tissue engineering

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,028,857
App. No.
12/681,676
Granted
May 12, 2015
Kind
B2
Abstract

The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b). characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a).

Claims (12)

1. A method for preparing a porous scaffold consisting of the steps of

a) preparing an alkaline aqueous solution consisting of an amount of at least one natural polysaccharide and one cross-linking agent;

b) freezing the aqueous solution of step a); and

c) sublimating the frozen solution of step b);

wherein the at least one natural polysaccharide is selected from the group consisting of dextran, agar, alginic acid, hyaluronic acid, inulin, pullulan, heparin, chitonsan, and fucoidan; and

wherein step b) is performed before the cross-linking of the natural polysaccharide and said cross-linking occurs during the sublimation step c).

2. The method according to claim 1 wherein said cross-linking agent is selected in the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl3), eupichlorohydrin, formaldehydes, water soluble carbodiimides, and glutaraldehydes.

3. The method according to claim 2 wherein said cross-linking agent is trisodium trimetaphosphate (STMP).

4. The method according to claim 1 wherein the aqueous solution of step a) is freeze-dried.

5. The method according to claim 4 wherein the aqueous solution of step a) is freeze-dried under a pressure from 0.1 mBar to 6.5 mBar.

6. The method according to claim 1 wherein the aqueous solution of step a) is poured in a mould before step b).

7. The method according to claim 1 wherein said scaffold is shaped.

Assignments (4)
CHANGE OF NAME Recorded Mar 25, 2022
From: UNIVERSITÉ DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059504/0225 →
MERGER Recorded Jul 22, 2021
From: UNIVERSITE DE PARIS DESCARTES; UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 056947/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2017
From: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE PARIS XIII PARIS-NORD; UNIVERSITE PARIS DESCARTES; INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PARIS DIDEROT - PARIS 7
Reel/Frame 043147/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2010
From: LE VISAGE, CATHERINE; LETOURNEUR, DIDIER; CHAUBET, FREDERIC; AUTISSIER, AUDE
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PARIS 7 - DENIS DIDEROT
Reel/Frame 024415/0103 →